Levi & Korsinsky, LLP Notifies Investors of Class Action Lawsuit Against ESSA Pharma Inc.

NEW YORK, Feb. 14, 2025 /PRNewswire/ — Levi & Korsinsky, LLP has announced a class action securities lawsuit against ESSA Pharma Inc. (NASDAQ: EPIX). This lawsuit aims to recover losses for investors who were impacted by alleged securities fraud between December 12, 2023 and October 31, 2024.

Class Definition

The class action lawsuit involves investors in ESSA Pharma Inc. who suffered financial losses due to the alleged securities fraud during the specified time period.

Effect on Investors

Investors in ESSA Pharma Inc. may have experienced losses as a result of the securities fraud, and this lawsuit provides them with the opportunity to seek compensation for their damages.

Effect on the World

The class action lawsuit against ESSA Pharma Inc. highlights the importance of transparency and accountability in the financial markets. By holding companies accountable for fraudulent activities, this legal action helps to protect investors and maintain the integrity of the investment landscape.

Conclusion

Overall, the class action lawsuit against ESSA Pharma Inc. serves as a reminder of the importance of conducting thorough due diligence and staying informed about the companies in which one chooses to invest. By seeking justice for affected investors, this legal action helps to promote fairness and integrity in the financial markets.